Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
923.1 INR | -2.05% | -2.83% | +21.56% |
May. 30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
May. 09 | Transcript : Alembic Pharmaceuticals Limited, Q4 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.56% | 2.17B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- APLLTD Stock
- News Alembic Pharmaceuticals Limited
- Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA